Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 18/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 15/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 14/20 | 0.44 |
| ▸ | MEN1 | O00255 | 12/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 12/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 12/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 12/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 11/20 | 0.44 |
| ▸ | USP2 | O75604 | 11/20 | 0.44 |
| ▸ | CLK4 | Q9HAZ1 | 10/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 8/20 | 0.44 |
| ▸ | MAPT | P10636 | 6/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.44 |
| ▸ | NT5E | P21589 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 6/20 | 0.43 |
| ▸ | TSHR | P16473 | 5/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | PPARA | Q07869 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30181280 | 0.80 | CYP1A2 (0.51) | CYP1A2CYP3A4CYP2D6MEN1KMT2A | |
| SCHEMBL13327687 | 0.80 | CYP1A2 (0.51) | CYP1A2CYP3A4CYP2D6MEN1KMT2A | |
| SCHEMBL30523855 | 0.78 | ALDH1A1 (0.52) | CYP1A2CYP3A4CYP2D6MEN1KMT2A | |
| SCHEMBL4107384 | 0.78 | NPC1 (0.56) | CYP1A2CYP3A4CYP2D6MEN1KMT2A | |
| SCHEMBL4116432 | 0.76 | PDGFRB (0.47) | CYP1A2MEN1KMT2AALDH1A1USP2 | |
| SCHEMBL4119429 | 0.75 | CYP2A6 (0.60) | CYP1A2CYP3A4CYP2D6MEN1KMT2A | |
| SCHEMBL18952015 | 0.74 | CYP1A2 (0.50) | CYP1A2CYP3A4CYP2D6MEN1KMT2A | |
| SCHEMBL3923034 | 0.73 | MAPK14 (0.45) | CYP1A2CYP3A4MEN1KMT2AHSD17B10 | |
| SCHEMBL3922874 | 0.71 | NPC1 (0.41) | ALDH1A1MAPTLMNA | |
| SCHEMBL3997209 | 0.71 | NPC1 (0.54) | CYP3A4ALDH1A1CYP2C19KDM4EPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090036430-A1 | PYRIDO(3,2-D)PYRIMIDINES AND PHARMACEUTICAL COMPOSITIONS USEFUL FOR MEDICAL TREATMENT | 4 AZA IP NV (BE) | 2009-02-05 | — | — | US | disclosed |
| US-20080004285-A1 | PYRIDO(3,2-D)PYRIMIDINES AND PHARMACEUTICAL COMPOSITIONS USEFUL FOR MEDICAL TREATMENT | 4 AZA IP NV (BE) | 2008-01-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080004285-A1 | PYRIDO(3,2-D)PYRIMIDINES AND PHARMACEUTICAL COMPOSITIONS USEFUL FOR MEDICAL TREATMENT | PNPO, TYMP, PNP | CYP1A2 223/4885CYP3A4 377/4885CYP2D6 88/4885 |
| US-20090036430-A1 | PYRIDO(3,2-D)PYRIMIDINES AND PHARMACEUTICAL COMPOSITIONS USEFUL FOR MEDICAL TREATMENT | PNPO, TYMP, PNP | CYP1A2 223/4885CYP3A4 377/4885CYP2D6 88/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.